Express Scripts Responds To Claims Of Lost GM Contract, HTA Employers


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


A Cleveland Research report Thursday said that Express Scripts Holding Company (NASDAQ:ESRX) lost its General Motors Company (NYSE:GM) contract, but Express Scripts spokesman Brian Henry declined to comment on “specific client wins or losses.”

However, Henry did issue responses to a number of other concerns raised in the firm’s report.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

On allegations that Express Scripts will lose employers affiliated with Health Transformation Alliance, Henry said, “HTA members are not obligated to move to another provider.”

Cleveland Research also claimed Express Scripts is more aggressive with pricing and is pursuing early renewals. Henry asserted that prices remain rational and competitive, and in response to claims of cost-cutting measures meant to offset industry pressures, he added that, “As always, we are focused on expense management and being efficient."

Finally, he confirmed the report’s note that the company successfully secured rebate business for some of its health-plan clients.

Express Scripts was trading lower at around $67 per share.

See also:

Citron Compares Express Scripts To Philidor: 'Culprit Behind Pharmaceutical Price Gouging'

Citron’s Left: Express Scripts Is The John Gotti Of Pharma, Adds Zero Value To System


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Posted In: NewsShort SellersTop StoriesExclusivesBrian HenryCitron ResearchCleveland Researchhealth Transformation Alliance